Avidor Shulman

Person

Rakefet, IL

People

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for decreasing soluble immune receptor CD28
- Patent number 12,139,534
- Issue date Nov 12, 2024
- BIOND BIOLOGICS LTD.
- Motti Hakim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against ILT2 and use thereof
- Patent number 12,071,479
- Issue date Aug 27, 2024
- BIOND BIOLOGICS LTD.
- Ilana Mandel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified DNase and uses thereof
- Patent number 11,814,657
- Issue date Nov 14, 2023
- Protalix Ltd.
- Lilach Chen Zeltsburg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against ILT2
- Patent number 11,236,162
- Issue date Feb 1, 2022
- Biond Biologies Ltd.
- Ilana Mandel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified DNase and uses thereof
- Patent number 11,225,648
- Issue date Jan 18, 2022
- Protalix Ltd.
- Lilach Chen Zeltsburg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized alpha-galactosidase and uses thereof
- Patent number 10,870,842
- Issue date Dec 22, 2020
- Protalix Ltd.
- Avidor Shulman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Stabilized α-galactosidase and uses thereof
- Patent number 10,280,414
- Issue date May 7, 2019
- Protalix Ltd.
- Avidor Shulman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid construct for expression of alpha-galactosidase in pla...
- Patent number 9,732,333
- Issue date Aug 15, 2017
- Protalix Ltd.
- Avidor Shulman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized alpha-galactosidase and uses thereof
- Patent number 9,708,595
- Issue date Jul 18, 2017
- Protalix Ltd.
- Avidor Shulman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dry powder formulations of dNase I
- Patent number 9,603,907
- Issue date Mar 28, 2017
- Protalix Ltd.
- Yoseph Shaaltiel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhalable liquid formulations of DNase I
- Patent number 9,603,906
- Issue date Mar 28, 2017
- Protalix Ltd.
- Yoseph Shaaltiel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized alpha-galactosidase and uses thereof
- Patent number 9,194,011
- Issue date Nov 24, 2015
- Protalix Ltd.
- Avidor Shulman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Saccharide-containing protein conjugates and uses thereof
- Patent number 8,742,079
- Issue date Jun 3, 2014
- Protalix Ltd.
- Avidor Shulman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INTRACELLULAR DELIVERY COMPOSITIONS
- Publication number 20240350648
- Publication date Oct 24, 2024
- BIOND BIOLOGICS LTD.
- Orit SHILOVITZKY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28
- Publication number 20240309094
- Publication date Sep 19, 2024
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- G01 - MEASURING TESTING
Information Patent Application
CD28 SHEDDING BLOCKING AGENTS
- Publication number 20240279335
- Publication date Aug 22, 2024
- BIOND BIOLOGICS LTD.
- Anna FRIDMAN-DROR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTRACELLULAR DELIVERY COMPOSITIONS
- Publication number 20240148886
- Publication date May 9, 2024
- BIOND BIOLOGICS LTD.
- Orit SHILOVITZKY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY COMPOSTIONS AND USE THEREOF
- Publication number 20240010706
- Publication date Jan 11, 2024
- BIOND BIOLOGICS LTD.
- Ilana MANDEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLUBLE CD28 LEVELS AFTER IMMUNOTHERAPY
- Publication number 20230221325
- Publication date Jul 13, 2023
- BIOND BIOLOGICS LTD.
- Anna FRIDMAN-DROR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SHEDDING BLOCKING AGENTS WITH INCREASED STABILITY
- Publication number 20230144459
- Publication date May 11, 2023
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF
- Publication number 20230074255
- Publication date Mar 9, 2023
- PROTALIX LTD.
- Avidor SHULMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF MMP INHIBITION
- Publication number 20230041599
- Publication date Feb 9, 2023
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY
- Publication number 20230035730
- Publication date Feb 2, 2023
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- G01 - MEASURING TESTING
Information Patent Application
SMALL SHEDDING BLOCKING AGENTS
- Publication number 20220169732
- Publication date Jun 2, 2022
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Against ILT2 and Use Thereof
- Publication number 20220153836
- Publication date May 19, 2022
- BIOND BIOLOGICS LTD.
- Ilana MANDEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A METHOD FOR IMMUNOSUPPRESSION
- Publication number 20220153845
- Publication date May 19, 2022
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED DNASE AND USES THEREOF
- Publication number 20220106578
- Publication date Apr 7, 2022
- PROTALIX LTD.
- Lilach CHEN ZELTSBURG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Against ILT2 and Use Thereof
- Publication number 20220048991
- Publication date Feb 17, 2022
- BIOND BIOLOGICS LTD.
- Ilana MANDEL
- G01 - MEASURING TESTING
Information Patent Application
Antibodies Against ILT2 and Use Thereof
- Publication number 20210277112
- Publication date Sep 9, 2021
- BIOND BIOLOGICS LTD.
- Ilana MANDEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28
- Publication number 20210047411
- Publication date Feb 18, 2021
- BIOND BIOLOGICS LTD.
- Motti HAKIM
- G01 - MEASURING TESTING
Information Patent Application
STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF
- Publication number 20190256832
- Publication date Aug 22, 2019
- PROTALIX LTD.
- Avidor SHULMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF
- Publication number 20180148703
- Publication date May 31, 2018
- PROTALIX LTD.
- Avidor SHULMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED DNASE AND USES THEREOF
- Publication number 20180112201
- Publication date Apr 26, 2018
- Lilach CHEN ZELTSBURG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF
- Publication number 20160053247
- Publication date Feb 25, 2016
- PROTALIX LTD.
- Avidor SHULMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DRY POWDER FORMULATIONS OF DNASE I
- Publication number 20150024050
- Publication date Jan 22, 2015
- PROTALIX LTD.
- Yoseph Shaaltiel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DNASE I POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, METHODS OF PRO...
- Publication number 20150010527
- Publication date Jan 8, 2015
- Yoseph Shaaltiel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHALABLE LIQUID FORMULATIONS OF DNASE I
- Publication number 20150010617
- Publication date Jan 8, 2015
- PROTALIX LTD.
- Yoseph Shaaltiel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SACCHARIDE-CONTAINING PROTEIN CONJUGATES AND USES THEREOF
- Publication number 20140256017
- Publication date Sep 11, 2014
- PROTALIX LTD.
- Avidor Shulman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACID CONSTRUCT FOR EXPRESSION OF ALPHA-GALACTOSIDASE IN PLA...
- Publication number 20130295065
- Publication date Nov 7, 2013
- PROTALIX LTD.
- Avidor Shulman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTIMERIC FORMS OF THERAPEUTIC PROTEINS AND USES THEREOF
- Publication number 20130017169
- Publication date Jan 17, 2013
- PROTALIX LTD.
- Ilya Ruderfer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLUCOCEREBROSIDASE MULTIMERS AND USES THEREOF
- Publication number 20120328589
- Publication date Dec 27, 2012
- Ilya Ruderfer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF
- Publication number 20120328592
- Publication date Dec 27, 2012
- PROTALIX LTD.
- Avidor Shulman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SACCHARIDE-CONTAINING PROTEIN CONJUGATES AND USES THEREOF
- Publication number 20110105379
- Publication date May 5, 2011
- PROTALIX LTD.
- Avidor Shulman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Avidor Shulman

Person

Patents Grantslast 30 patents

Methods and compositions for decreasing soluble immune receptor CD28

Antibodies against ILT2 and use thereof

Modified DNase and uses thereof

Antibodies against ILT2

Modified DNase and uses thereof

Stabilized alpha-galactosidase and uses thereof

Stabilized α-galactosidase and uses thereof

Nucleic acid construct for expression of alpha-galactosidase in pla...

Stabilized alpha-galactosidase and uses thereof

Dry powder formulations of dNase I

Inhalable liquid formulations of DNase I

Stabilized alpha-galactosidase and uses thereof

Saccharide-containing protein conjugates and uses thereof

Patents Applicationslast 30 patents

INTRACELLULAR DELIVERY COMPOSITIONS

METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28

CD28 SHEDDING BLOCKING AGENTS

INTRACELLULAR DELIVERY COMPOSITIONS

IMMUNOMODULATORY COMPOSTIONS AND USE THEREOF

SOLUBLE CD28 LEVELS AFTER IMMUNOTHERAPY

SHEDDING BLOCKING AGENTS WITH INCREASED STABILITY

STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF

USE OF MMP INHIBITION

SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY

SMALL SHEDDING BLOCKING AGENTS

Antibodies Against ILT2 and Use Thereof

A METHOD FOR IMMUNOSUPPRESSION

MODIFIED DNASE AND USES THEREOF

Antibodies Against ILT2 and Use Thereof

Antibodies Against ILT2 and Use Thereof

METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28

STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF

STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF

MODIFIED DNASE AND USES THEREOF

STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF

DRY POWDER FORMULATIONS OF DNASE I

DNASE I POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, METHODS OF PRO...

INHALABLE LIQUID FORMULATIONS OF DNASE I

SACCHARIDE-CONTAINING PROTEIN CONJUGATES AND USES THEREOF

NUCLEIC ACID CONSTRUCT FOR EXPRESSION OF ALPHA-GALACTOSIDASE IN PLA...

MULTIMERIC FORMS OF THERAPEUTIC PROTEINS AND USES THEREOF

GLUCOCEREBROSIDASE MULTIMERS AND USES THEREOF

STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF

SACCHARIDE-CONTAINING PROTEIN CONJUGATES AND USES THEREOF